Psychosis in Parkinson's disease

被引：30
|
作者：
Thanvi, BR
Lo, TCN
Harsh, DP
机构：
[1] Univ Hosp Leicester NHS Trust, Leicester Gen Hosp, Dept Med Older People, Leicester LE5 4PW, Leics, England
[2] Hellesdon Hosp, Norwich, Norfolk, England
来源：
POSTGRADUATE MEDICAL JOURNAL | 2005年 / 81卷 / 960期
关键词：
D O I：
10.1136/pgmj.2004.032029
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Psychosis is common in Parkinson's disease (PD), particularly in its later stages. The symptoms range from comparatively minor illusions, vivid dreams, and occasional, non-disturbing visual hallucinations to frank psychosis. The pathogenesis of psychosis in PD is not fully known. Management of psychosis in PD requires a multidisciplinary approach. Some of the newer atypical antipsychotics are effective against psychosis with no significant worsening of PD. Psychosis in PD is associated with poor quality of life for patients and the carers.
引用
收藏
页码：644 / 646
页数：3
相关论文
共 50 条
  • [21] Management of psychosis in Parkinson's disease
    D'Souza, C
    Gupta, A
    Alldrick, MD
    Sastry, BSD
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2003, 57 (04) : 295 - 300
  • [22] Psychosis in Prodromal Parkinson's disease
    Pachi, I.
    Maraki, M.
    Kosmidis, M.
    Yannakoulia, M.
    Dardiotis, E.
    Hadjigeorgiou, G.
    Sakka, P.
    Xiromerisiou, G.
    Stamelou, M.
    Scarmeas, N.
    Stefanis, L.
    MOVEMENT DISORDERS, 2019, 34 : S154 - S154
  • [23] Managing psychosis in Parkinson's disease
    Friedman, Joseph H.
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2011, 1 (03) : 217 - 226
  • [24] Epidemiology of psychosis in Parkinson's disease
    Fenelon, Gilles
    Alves, Guido
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2010, 289 (1-2) : 12 - 17
  • [25] Psychosis and depression in Parkinson's disease
    Brandstädter, D
    Oertel, WH
    PARKINSON'S DISEASE, 2002, 1 : 29 - 38
  • [26] Parkinson psychosis rating scale: A practical instrument for grading psychosis in Parkinson's disease
    Friedberg, G
    Zoldan, J
    Weizman, A
    Melamed, E
    CLINICAL NEUROPHARMACOLOGY, 1998, 21 (05) : 280 - 284
  • [27] Pimavanserin for the treatment of Parkinson's disease psychosis
    Friedman, Joseph H.
    EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (14) : 1969 - 1975
  • [28] PSYCHOSIS IN PARKINSON'S DISEASE: THERAPEUTIC OPTIONS
    Hasnain, M.
    DRUGS OF TODAY, 2011, 47 (05) : 353 - 367
  • [29] Antipsychotics for the management of Parkinson's disease psychosis
    Jethwa, Ketan Dipak
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2017, 32 (04) : 464 - 465
  • [30] Psychopharmacologic management of psychosis in Parkinson's Disease
    Quitangon, GD
    Rosales-Eder, L
    BIOLOGICAL PSYCHIATRY, 2003, 53 (08) : 41S - 42S
12345